LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 5.36 | 27.76 | 635 | 320 | 1.9822 | 1.4279 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 5.36 | 27.76 | 727 | 320 | 2.2693 | 1.5228 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.06 | 27.76 | 668 | 360 | 1.8556 | 1.3640 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.06 | 27.76 | 775 | 360 | 2.1528 | 1.4610 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 8.76 | 27.76 | 718 | 401 | 1.7899 | 1.3262 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 8.76 | 27.76 | 818 | 401 | 2.0392 | 1.4063 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 10.46 | 27.76 | 709 | 438 | 1.6163 | 1.2563 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 10.46 | 27.76 | 6 | 438 | 0.0137 | -0.3193 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 10.46 | 27.76 | 859 | 438 | 1.9583 | 1.3677 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.17 | 27.76 | 2 | 489 | 0.0041 | -0.4703 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.17 | 27.76 | 762 | 489 | 1.5581 | 1.2262 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.17 | 27.76 | 6 | 489 | 0.0123 | -0.3093 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.17 | 27.76 | 930 | 489 | 1.9016 | 1.3360 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 13.87 | 27.76 | 4 | 604 | 0.0066 | -0.3533 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 13.87 | 27.76 | 702 | 604 | 1.1609 | 1.0683 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 13.87 | 27.76 | 8 | 604 | 0.0132 | -0.2441 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 13.87 | 27.76 | 920 | 604 | 1.5214 | 1.1980 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 15.58 | 27.76 | 4 | 685 | 0.0058 | -0.3421 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 15.58 | 27.76 | 824 | 685 | 1.2019 | 1.0811 | MN20160318_Q01 | H15 |